|
1.
|
|
10 p, 659.8 KB |
A Pharmacovigilance Study in First Episode of Psychosis : Psychopharmacological Interventions and Safety Profiles in the PEPs Project
/
Bioque, Miquel (Hospital Clínic i Provincial de Barcelona) ;
Llerena, Adrián (Universidad de Extremadura) ;
Cabrera, Bibiana (Hospital Clínic i Provincial de Barcelona) ;
Mezquida, Gisela (Hospital Clínic i Provincial de Barcelona) ;
Lobo, Antonio (Universidad de Zaragoza) ;
González-Pinto, Ana (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Díaz-Caneja, Covadonga M. (Hospital General Universitario Gregorio Marañón) ;
Corripio, Iluminada (Institut d'Investigació Biomèdica Sant Pau) ;
Aguilar, Eduardo J. (Hospital Clínic València) ;
Bulbena Vilarrasa, Antonio (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Castro-Fornieles, Josefina (Hospital Clínic i Provincial de Barcelona) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Lafuente, Amàlia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Mas, Sergi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Parellada, Mara (Hospital General Universitario Gregorio Marañón) ;
Saiz-Ruiz, Jerónimo (Hospital Ramon y Cajal) ;
Cuesta, Manuel J. (Instituto de Investigación Sanitaria de Navarra) ;
Bernardo, Miguel (Universitat de Barcelona) ;
Gassó, P. ;
Amoretti, S. ;
García Bernardo, E. ;
Tapia-Casellas, C. ;
Alonso-Solís, Anna (Institut d'Investigació Biomèdica Sant Pau) ;
Grasa, Eva (Institut d'Investigació Biomèdica Sant Pau) ;
Hernández, M. ;
González, I. ;
Ruiz, P. ;
Modrego, F. ;
Escartí, M.J. ;
Mané, A. ;
Torrent, C. ;
Baeza, I. ;
Contreras, F. ;
Albacete, A. ;
Bobes, Julio ;
García-Portilla, Maria Paz ;
Zabala Rabadán, A. ;
Segarra Echevarría, R. ;
Rodriguez-Jimenez, R. ;
Morales-Muñoz, I. ;
Butjosa, A. ;
Landin-Romero, R. ;
Sarró, S. ;
Ibáñez, Á. ;
Sánchez-Torres, A.M. ;
Balanzá-Martínez, V. ;
Universitat Autònoma de Barcelona
The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of first episode of psychosis attended in daily practice. [...]
2016 -  10.1093/ijnp/pyv121
International journal of neuropsychopharmacology, Vol. 19 Núm. 4 (january 2016)
|
|
|
2.
|
|
12 p, 1.3 MB |
The Need for the Closer Monitoring of Novel Drugs in MS : A Siponimod Retrospective Cohort Study (Realhes Study)
/
Sancho-López, Arantxa (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Ruiz-Antorán, Belén (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Iglesias Hernangómez, Teresa (Hospital Universitario Clínico San Carlos (Madrid)) ;
Ramírez-García, Almudena (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Gómez-Estévez, Irene (Universidad Complutense de Madrid) ;
Sanabria-Cabrera, Judith (Plataforma ISCIII de Investigación Clínica) ;
Llop Rius, Roser (Hospital Universitari de Bellvitge) ;
Pedrós, Consuelo (Hospital General Universitario de Valencia) ;
Campodonico, Diana (Hospital Universitario de la Princesa (Madrid)) ;
Jiménez-Jorge, Silvia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
García Luque, Amelia (University of Alcalá (IRYCIS)) ;
Costa-Frossard, Lucienne (Hospital Universitario Ramón y Cajal (Madrid)) ;
Montané Esteva, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aldea-Perona, Ana (Hospital del Mar (Barcelona, Catalunya)) ;
Téllez Lara, Nieves (Hospital Clínico Universitario de Valladolid) ;
Bosch Ferrer, Montserrat (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rodriguez Jiménez, Consuelo (Complejo Hospitalario Universitario e Canarias) ;
Bonilla-Toyos, Elvira (Plataforma ISCIII de Investigación Clínica) ;
Sabín Muñoz, Julia (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Avendaño Sola, Cristina (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Blasco Quilez, María Rosario (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Universitat Autònoma de Barcelona
Severe cases of lymphopenia have been reported during siponimod clinical trials, which may negatively impact its benefit/risk profile. We aimed to evaluate the incidence of lymphopenia following the initiation of siponimod treatment in clinical practice. [...]
2023 - 10.3390/jcm12206471
Journal of clinical medicine, Vol. 12 (october 2023)
|
|
|
3.
|
|
14 p, 928.6 KB |
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
/
Sabaté, Mònica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pérez, Eulàlia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Garcia Doladé, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vidal Guitart, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Carreras Soler, Maria Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Farriols Danés, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Braña, Irene (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Carles, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Morales-Barrera, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Muñoz Couselo, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Agustí Escasany, M. Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Data related to adverse drug reactions (ADRs), specifically immune-related adverse events (irAEs), in long-term treatment with immunotherapy in real-world practice is scarce, as is general information regarding the management of ADRs. [...]
2022 - 10.3389/fmed.2022.891179
Frontiers in Medicine, Vol. 9 (august 2022)
|
|
|
4.
|
|
12 p, 1.6 MB |
Myocarditis and pericarditis associated with SARS-CoV-2 vaccines : A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
/
Bots, Sophie H. (Utrecht University) ;
Riera-Arnau, Judit (Hospital Universitari Vall d'Hebron) ;
Belitser, Svetlana V. (Utrecht University) ;
Messina, Davide (Agenzia Regionale di Sanitá) ;
Aragón, María (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Alsina, Ema (Hospital Universitari Vall d'Hebron) ;
Douglas, Ian J. (London School of Hygiene & Tropical Medicine) ;
Durán, Carlos E. (Hospital Universitari Vall d'Hebron) ;
García-Poza, Patricia (Agencia Española de Medicamentos y Productos Sanitarios) ;
Gini, Rosa (Agenzia Regionale di Sanitá) ;
Herings, Ron M. C. (PHARMO Institute for Drug Outcomes Research) ;
Huerta, Consuelo (Agencia Española de Medicamentos y Productos Sanitarios) ;
Sisay, Malede Mequanent (Hospital Universitari Vall d'Hebron) ;
Martín-Pérez, Mar (Agencia Española de Medicamentos y Productos Sanitarios) ;
Martin, Ivonne (Hospital Universitari Vall d'Hebron) ;
Overbeek, Jetty A. (PHARMO Institute for Drug Outcomes Research) ;
Paoletti, Olga (Agenzia Regionale di Sanitá) ;
Pallejà-Millán, Meritxell (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Schultze, Anna (London School of Hygiene & Tropical Medicine) ;
Souverein, Patrick (Utrecht University) ;
Swart, Karin M. A. (PHARMO Institute for Drug Outcomes Research) ;
Villalobos Martínez, Felipe (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ;
Klungel, Olaf H. (Utrecht University) ;
Sturkenboom, Miriam (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Background: Estimates of the association between COVID-19 vaccines and myo-/pericarditis risk vary widely across studies due to scarcity of events, especially in age- and sex-stratified analyses. Methods: Population-based cohort study with nested self-controlled risk interval (SCRI) using healthcare data from five European databases. [...]
2022 - 10.3389/fphar.2022.1038043
Frontiers in Pharmacology, Vol. 13 (november 2022)
|
|
|
5.
|
|
|
6.
|
|
15 p, 324.4 KB |
Spontaneous reporting of adverse drug reactions in a pediatric population in a tertiary hospital
/
López Valverde, Laura (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Domènech Marsal, Èlia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Roguera, M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gich, Ignasi (Institut d'Investigació Biomèdica Sant Pau) ;
Farre, Magi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rodrigo Gonzalo de Líria, Carlos (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Montané, E. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
The pediatric population is a vulnerable group for adverse drug reactions (ADRs), and data on spontaneous reporting of ADRs in the hospital setting are scarce. We conducted a retrospective analysis of ADRs in pediatric patients spontaneously reported by health care professionals to a Pharmacovigilance Program in a tertiary hospital between 2010 and 2020, and we compared characteristics of ADRs between pediatric age subgroups. [...]
2021 - 10.3390/jcm10235531
Journal of clinical medicine, Vol. 10 Núm. 23 (12-1 2021) , p. 5531
|
|
|
7.
|
|
10 p, 253.6 KB |
Spontaneously reported adverse drug reactions and their description in hospital discharge reports : a retrospective study
/
Aguilera, Cristina (Hospital Universitari Vall d'Hebron) ;
Agustí Escasany, M. Antònia (Hospital Universitari Vall d'Hebron) ;
Pérez, Eulàlia (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Gracia, Rosa Maria (Hospital Universitari Vall d'Hebron) ;
Diogène Fadini, Eduard (Hospital Universitari Vall d'Hebron) ;
Danés Carreras, Immaculada (Hospital Universitari Vall d'Hebron)
The inclusion of spontaneously reported adverse drug reactions (ADRs) in hospital discharge reports was examined, in addition to the factors associated with their inclusion, the resulting therapeutic decisions, and any recommendations made upon patient discharge regarding the suspected offending drugs. [...]
2021 - 10.3390/jcm10153293
Journal of clinical medicine, Vol. 10 Núm. 15 (january 2021) , p. 3293
|
|
|
8.
|
|
|
9.
|
|
9 p, 611.2 KB |
Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
/
Amaro-Hosey, Kristopher (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Danés Carreras, Immaculada (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vendrell Bosch, Lourdes (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alonso, Laura (Vall d'Hebron Institut d'Oncologia) ;
Renedo-Miró, Berta (Hospital Universitari Vall d'Hebron) ;
Gros, Luis (Vall d'Hebron Institut d'Oncologia) ;
Vidal Guitart, Xavier (Hospital Universitari Vall d'Hebron) ;
Cereza García, Gloria (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Agustí Escasany, M. Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Introduction: Drugs used in oncological diseases are frequently related to adverse drug reactions (ADR). Few studies have analyzed the toxicity of cancer treatments in children in real practice. Methods: An observational, longitudinal and prospective study has been carried out in an Oncohematology Service of a tertiary hospital. [...]
2021 - 10.3389/fphar.2021.670945
Frontiers in Pharmacology, Vol. 12 (may 2021)
|
|
|
10.
|
|
14 p, 1.2 MB |
Safer prescription of drugs : impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia
/
Pons-Mesquida, M. Àngels (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Oms-Arias, Míriam (Institut Català de la Salut. Unitat de Coordinació i Estratègia del Medicament) ;
Diogène Fadini, Eduard (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
In 2008, the Institut Català de la Salut (ICS, Catalan Health Institute) implemented a prescription decision support system in its electronic clinical workstation (ECW), which automatically generates online alerts for general practitioners when a possible medication-related problem (MRP) is detected. [...]
2021 - 10.1186/s12911-021-01710-8
BMC Medical Informatics and Decision Making, Vol. 21 (december 2021)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
